{
    "2019-05-28": [
        [
            {
                "time": "",
                "original_text": "嘉事堂|别用1%的业务，摧毁100%的名誉",
                "features": {
                    "keywords": [
                        "嘉事堂",
                        "业务",
                        "名誉"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)提名徐有利、忻铿为监事候选人",
                "features": {
                    "keywords": [
                        "上海医药",
                        "监事候选人",
                        "徐有利",
                        "忻铿"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)提名左敏、李永忠和沈波为执行董事候选人",
                "features": {
                    "keywords": [
                        "上海医药",
                        "执行董事",
                        "左敏",
                        "李永忠",
                        "沈波"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "港股异动 | 复旦张江涨逾4% 冲击A+H 国家队间接持股",
                "features": {
                    "keywords": [
                        "复旦张江",
                        "港股",
                        "涨逾4%",
                        "国家队持股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中生制药获德银吁买入 现飙近3%",
                "features": {
                    "keywords": [
                        "中生制药",
                        "德银",
                        "买入",
                        "飙近3%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "业绩萎靡深陷亏损 哈药股份内忧外困 亏损",
                "features": {
                    "keywords": [
                        "哈药股份",
                        "业绩萎靡",
                        "亏损"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}